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Voltage-dependent anion channels (VDACs), also known as mitochondrial porins, are the main pathway for metabolites across the
mitochondrial outer membrane and may serve as binding sites for kinases, including hexokinase. We determined that mitochondria-bound
hexokinase activity is significantly reduced in oxidative muscles (heart and soleus) in vdac1−/− mice. The activity data were supported by western
blot analysis using HK2 specific antibody. To gain more insight into the physiologic mean of the results with the activity data, VDAC deficient
mice were subjected to glucose tolerance testing and exercise-induced stress, each of which involves tissue glucose uptake via different
mechanisms. vdac1−/− mice exhibit impaired glucose tolerance whereas vdac3−/− mice have normal glucose tolerance and exercise capacity. Mice
lacking both VDAC1 and VDAC3 (vdac1−/−/vdac3−/−) have reduced exercise capacity together with impaired glucose tolerance. Therefore, we
demonstrated a link between VDAC1 mediated mitochondria-bound hexokinase activity and the capacity for glucose clearance.
© 2006 Elsevier B.V. All rights reserved.Keywords: Mitochondrial outer membrane; Muscle; Porin; Hexokinase; Glucose clearance; Exercise capacity1. Introduction
Two groups of kinases are found in the mitochondria: energy
consuming kinases at the outer surface (e.g., acyl-CoA-
synthetase, hexokinase and glycerol kinase) and energy
transmitting kinases in the intermembrane space (e.g., adenylate
kinase, creatine kinase and nucleoside diphosphate kinase). By
converting glucose to glucose 6-phosphate, hexokinase (HK)
helps maintain the glucose concentration gradient that results in
the movement of glucose into cells through the facilitative
glucose transporters. In skeletal muscle and heart, HK2 is the
major hexokinase isoform. The enzyme is either located in the
cytosol or associated with the mitochondria, a property termed
“ambiquitous” [1,2]. Skeletal muscle is a primary site for both
insulin- and exercise-stimulated glucose disposals. In rodent
and human skeletal muscle, HK2 is subject to regulation since
insulin and muscle contraction increases the expression of HK2⁎ Corresponding author. Tel.: +1 713 798 8606; fax: +1 713 798 8777.
E-mail address: ayapharayra@yahoo.com (K. Anflous-Pharayra).
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doi:10.1016/j.bbabio.2006.11.013but not HK1 [3–5]. During resting conditions, the transport step
exerts the most control in regulating muscle glucose uptake, as
GLUT1 or GLUT4 overexpression augments basal muscle
glucose uptake [6–11]. Hyperinsulinemia and exercise shift the
control of muscle glucose uptake so that glucose phosphory-
lation is a more important determinant of the rate of this process.
Indeed, transgenic mice overexpressing HK2 required 25%
more glucose to maintain euglycemia during hyperinsulinemic
experiments. When exercise-induced glucose uptake was
assessed, muscle 2-deoxy-[3H] glucose accumulation was
significantly greater [12]. Recently, it has been reported that
in mice heterozygous for a HK2 null allele, exercise-stimulated
glucose uptake in oxidative muscles is impaired [13]. This
impairment is critically dependent on metabolic activity and
associated glucose flux. Whereas muscle glucose uptake has
been separated into three sequential steps: delivery of glucose
from the blood to the muscle, transport across the sarcolemma
and irreversible phosphorylation to glucose-6-phosphate; the
possibility that mitochondria-bound hexokinase activity could
constitute an additional control step has not been definitely
addressed.
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forming proteins found in the mitochondrial outer membrane
(MOM) of all eukaryotes [14]. In mammals, three VDAC
isoforms have been characterized: VDAC1, VDAC2 and
VDAC3 [15–20]. We have previously reported that all three
VDAC isoforms are expressed in wild type muscles. It has
previously been demonstrated that the pore protein and the
hexokinase binding protein from the MOM of rat liver
mitochondria are identical [21,22] and that, in vitro, hexokinase
and VDAC form complexes [23]. It is believed that, in vivo,
kinase:VDAC interaction facilitates the access of kinases to
ATP and overcomes the restriction that the MOM exerts on the
permeability for the metabolites [24–26].
Mice lacking the expression of VDAC1 (vdac1−/−) or
VDAC3 (vdac3−/−) have been generated by gene targeting in
embryonic stem cells [27–29]. Double mutant mice (vdac1−/−/
vdac3−/−) have been obtained by intercrossing vdac1+/− and
vdac3+/− mice. Although vdac1−/− and double mutant mice
exhibit partial lethality in utero, the live born mice are viable
and do not exhibit any cardiovascular structural abnormalities.
However, vdac1−/− and vdac1−/−/vdac3−/− mice are growth
retarded. We expected that the absence of VDAC will alter the
amount of mitochondria-bound hexokinase, leading to altered
substrate utilization. We therefore measured total and mito-
chondria-bound hexokinase activities. Two approaches were
used to indirectly examine substrate utilization in VDAC
deficient mice: we challenged VDAC deficient mice by glucose




All experiments using animals were conducted using protocols approved by
the Baylor College of Medicine Institutional Animal Care and Use Committee.
Male and female vdac1−/−, vdac3−/− and vdac1−/−/vdac3−/− mice were used in
the present study. Mice were CD1 (vdac1−/− mice), C57BL6 (vdac3−/− mice) or
C57BL6/129SvEv (vadc1−/− mice in the growth experiment and vac1−/−/
vdac3−/− mice) strains. Six months old male and female wild type littermates
served as age-matched controls. Genotyping of the mice was performed via PCR
analysis [27–29]. Isolation of mouse tail DNAwas performed with the DNeasy
tissue kit (Qiagen) according to the manufacturer's instructions.
2.2. Hexokinase activity
Fresh heart and soleus were homogenized (50 mg/ml) using an Ultra-Turax
Polytron in 5 mM HEPES buffer (pH 8.0) containing 1 mM EDTA, 1 mM
dithiothreitol (DTT) and 0.1% Triton X-100. Homogenates were allowed to sit
on ice for 1 h then centrifuged at 2,500 rpm, 5 min. Total hexokinase activity
was measured on the supernatant in the presence of 20 mM HEPES (pH 8.0),
20 mM glucose, 0.5 mM DTT, 5 mM MgCl2, 1.5 mM ATP, 0.5 mM NADP
and 5 U glucose 6-phosphate dehydrogenase. A coupled enzyme system was
used to follow the rate of NADPH formation at 340 nm, 25 °C [30]. To
measure the mitochondria-bound hexokinase activity, the same assay was
performed on permeabilized muscle fibers, as previously described [31]. The
sarcolemmal membrane was permeabilized as previously described for mice
[27,32]. Fiber bundles from the endocardium and soleus were placed in a
cooled solution S (pH 7.1) containing 1.9 mM CaK2EGTA, 8.1 mM K2EGTA,
9.44 mM MgCl2, 3 mM KH2PO4, 2.5 mM Na2ATP, 15 mM phosphocreatine,
0.5 mM DTT, 53 mM potassium methanesulfonate, 20 mM imidazole, 20 mM
taurine and incubated in the presence of 50 μg/ml saponin with mild agitationfor 30 min, 4 °C. The bundles were then washed twice in solution S without
PCr and Na2ATP for 10 min. The skinned fibers were then weighed and
homogenized as described above. The hexokinase activity determined on the
skinned fibers homogenates represents the mitochondria-bound hexokinase
activity [31].
2.3. Western blotting
Five to ten μg of the sample homogenates from the hexokinase assay
were separated using a 12% ready-gel (Bio-Rad) and transferred to poly-
vinylidene difluoride membrane (Bio-Rad) using a Bio-Rad Trans-Blot
system. A prestained, broad range standard was used as a molecular weight
marker (161–0372, Bio-Rad). The membranes were blocked in 5% milk/1×
Tris Borate SDS (TBS), 0.05% Tween and incubated with an affinity column
purified rabbit polyclonal antibody raised against the rat HK2 (kind gift from
Dr. John E. Wilson) [33] for 2 h at room temperature. A rabbit polyclonal
antibody for actin was used as a loading control (A2066, Sigma). The dilution
was 1:2,000 for both HK2 and actin. A mouse anti-rabbit IgG HRP conjugate
(Sigma) was used at a final dilution of 1:10,000. The membranes were
developed using an ECL plus Western Blotting Detection System (RPN 2132,
Amersham Biosciences) and developed using Blue X-ray Film BX (F-BX810,
Phenix Research Products). Protein was determined with the BCA reagent
(#23225, Pierce) with BSA as standard.
2.4. Glucose tolerance testing
Mice from control and VDAC deficient groups were fasted for 16 h. D-
Glucose (1.2 mg/g weight) was injected into the peritoneum of conscious mice.
Blood was obtained from the tail at 0, 30, 60, 90 and 120 min after injection and
glucose concentration was determined with an Elite glucose meter (Glucometer
Elite, Bayer).
2.5. Incremental treadmill exercise
The treadmill apparatus (Columbus Instruments, Columbus, Ohio, USA)
employs a moving belt encased in a Plexiglas enclosure, assuring that the
mouse remains on the belt and allowing for body mass-corrected oxygen
consumption and carbon dioxide production measurements. The apparatus is
equipped with an electrified grid at the rear of the belt to provide motivation.
We used a protocol similar to the one used by Graham et al. [34], with some
minor changes. After an initial ∼20 min baseline, the mice were subjected to
a ∼20 min exercise protocol, under constant supervision, during which the
workload was increased every 90 s by increasing the belt speed and/or the
belt incline. We started the exercise with 5 m/min at 0° incline and ended
with 17 m/min at 25° incline (Fig. 5A). We defined fatigue when the animal
sat on the electric grid for at least 10 s. At this point, we stopped the electric
shock and allowed the animal to recover. We measured the percentage of
completion of the protocol in controls and VDACs deficient mice. To
acclimate to the system, each mouse was subjected to a 10 min run (5 m/min,
0° incline) the day before the actual experiments. Gas exchange was
measured using a computer-controlled open-circuit indirect calorimeter
(Oxymax, Columbus Instruments) with an air flow of 0.5 l/min at 22 °C.
Gas samples were dried, measured and averaged at 90 s intervals using
Oxymax software. Calibration of the O2 and CO2 gas analyzers was
performed daily using a standard gas mixture (0.5% CO2–20.5% O2–
balanced with N2).
2.6. Plasma glucose and lactate determination
Blood (∼ 200 μl) was collected from the mouse tail vein. Serum glucose and
lactate were determined using a glucose/lactate analyzer (2300 STAT PLUS,
YSI).
2.7. Statistical analysis
A Student t-test was used to analyze data. P<0.05 was set as level of
significance.
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control groups. P<0.05 was set as level of significance.
3. Results
3.1. Mice
To determine whether the absence of VDAC affects growth,
we followed the growth rate in control and VDAC deficient
mice on mixed or inbred backgrounds fed ad libitum. The adult
vdac1−/− mice exhibited mild growth retardation on mixed
background that did not reach the level of significance. Growth
retardation was more pronounced in vdac1−/−/vdac3−/− mice
when compared to littermate controls (P<0.05) (Fig. 1A).
There was no growth deficiency in vdac3−/− mice maintained
on a C57BL6 background (Fig. 1B). vdac2−/− mice were not
available for study.
3.2. Hexokinase activity
Due to the difference in background, we represented the
activity in the different VDAC deficient group as a percentage
of the corresponding wild type control. By measuring theFig. 1. Weight curves of wild type and different VDAC deficient mice. Mice, fed
ad libitum, were weighed weekly for up to ∼40 weeks. A) Male mice on C57/
129SvEv background (wild type square n=6, vdac1−/− triangle n=5, vdac1−/−/
vdac3−/− inversed triangle, P<0.05 vs. wild type, n=3). B) Male mice on
C57BL6 inbred background (wild type square n=3, vdac3−/− triangle n=4).
Fig. 2. Total and mitochondria-bound hexokinase activity from different muscle
groups: (A) in heart, (B) in soleus. The activities in different VDAC deficient
muscles are represented as percentage of their corresponding wild type activity.
The different values represent the Mean±SD, n=6, *P<0.05 vs. wild type
using a Student t-test. Total and S.F. represent sample homogenate from total
and skinned fibers preparations.hexokinase activity in heart and soleus from wild type and
VDAC deficient mice, we observed a significant decrease in the
mitochondria-bound hexokinase activity in vdac1−/− mice,
whereas in vdac3−/− mice the activity is indistinguishable from
wild type controls (Fig. 2). This decrease can be directly
correlated with the absence of VDAC1, since the total
hexokinase activity is not significantly different from the wild
type.
3.3. Western blotting
To verify that the decrease in hexokinase activity correlates
with a decrease in mitochondria-bound hexokinase protein,
aliquots from wild type and VDAC deficient skinned fibers
homogenates used in the hexokinase activity assay were
analyzed by using a HK2 specific antibody. The enzymatic
activity data correlated with the protein content in the skinned
fibers prepared from vdac1−/− heart that shows a decrease in the
amount of HK2 (Fig. 3A). Due to the size of the soleus muscle
from vdac1−/− mice, we could not perform the western blot
analysis on this muscle. HK2 amount in vdac3−/− muscles is
indistinguishable from wild type muscles (Fig. 3B).
3.4. Glucose tolerance
While hexokinase binding to mitochondria has been reported
repeatedly, the question of whether the hexokinase binding to
Fig. 3. Western blots corresponding to the total and mitochondria-bound
hexokinase from wild type and different VDAC deficient muscles; (A) in
vdac1−/− heart, (B) in vdac3−/− heart and soleus. The different blots have been
probed with HK2 specific antibody and an anti-actin as loading control as
described in Experimental procedures. Total and S.F. represent sample
homogenate from total and skinned fibers preparations.
Fig. 4. Glucose tolerance curve in wild type (square) and different VDAC
deficient (triangle) groups. (A) Wild type vs. vdac1−/− mice (n=8 for each
groups). (B) Wild type vs. vdac3−/− mice (n=8 for each group). The different
time point values represent the Mean±SD, *P<0.05 vs. wild type, **P<0.01
vs. wild type, ***P<0.001 vs. wild type.
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muscle glucose utilization in vivo has not previously been
rigorously addressed. In mammals, skeletal muscle is a primary
target for the stimulation of glucose transport by a variety of
activators. These include insulin and stimuli that increase
energy demand such as exercise. To determine whether VDAC
deficient mice have an altered glucose clearance, we measured
glucose tolerance of different VDAC deficient groups. While
vdac3−/− mice exhibit a glucose tolerance curve indistinguish-
able from wild type controls, vdac1−/− mice have an impaired
glucose tolerance (Fig. 4). vdac1−/−/vdac3−/− mice have also
impaired glucose tolerance (data not shown).
3.5. Treadmill exercise
Treadmill exercise is typically used for inducing graded
physiologic stress in evaluating the response of various organ
systems [34,35]. While single mutant mice exhibited an
exercise tolerance indistinguishable from control mice, double
mutant mice showed a reduced capacity for exercise (Fig. 5B).
The contribution of anaerobic metabolism to overall energy
production during exercise can be estimated by calculating the
respiratory exchange ratio (ratio of VCO2 to VO2 or RER).
Under increasing workloads none of the groups tested reached a
RER value higher than 1, therefore none of these groups
reached their maximum aerobic capacity within the context of
the present study. However, the vdac1−/−/vdac3−/− group had asignificantly lower RER at the end of the exercise period (Fig.
6A), due to a relatively higher rate of O2 consumption (data not
shown). This result is consistent with a relatively higher
contribution of lipids to overall metabolism in the double
mutant mice [36].
Lactate levels were not significantly different between the
control and the double mutant mice, both at rest (4.09±
0.36 mM in wild type vs. 4.52±0.32 mM in vdac1−/−/vdac3−/−
mice) and after the exercise (13.3±0.82 mM in wild type vs.
12.0±1.09 mM in vdac1−/−/vdac3−/− mice). However, although
the serum glucose level at rest was indistinguishable between
the control and the double mutant mice (9.89±0.45 mM in the
control vs. 8.94±0.91 mM in the double mutant mice), after
exercise the serum glucose concentration was significantly
higher in the double mutant mice (12.0±0.77 mM in vdac1−/−/
vdac3−/− mice versus 8.94±0.91 mM in control, P<0.05) (Fig.
6B). Taken together, these results might suggest that vdac1−/−/
vdac3−/− mice utilize less glucose when exercised.
4. Discussion
Since it has long been held that a VDAC is the mitochondrial
receptor for hexokinase, we speculated that the absence of
VDAC would alter mitochondria-bound hexokinase. If mito-
chondria-bound hexokinase activity plays a regulatory role in
Fig. 5. Exercise testing in wild type and different VDAC deficient mice. (A)
Scheme of the treadmill test. (B) Exercise tolerance of wild type and different
VDAC deficient mice. Mice were exercised as described in Experimental
procedures until exhaustion, and then the percentage of completion of the test
was determined. Black bar=wild type group (n=12); White bar=different
VDAC deficient groups (n≥6). The different graphs represent Mean±SEM,
***P<0.001 vs. wild type using a Student t-test.
Fig. 6. The respiratory exchange ratio (RER) and serum glucose were
significantly decreased and increased respectively at the end of the exercise in
vdac1−/−/vdac3−/− mice. (A) RER of wild type (black bar) and different VDAC
deficient mice (white bar) at the end of the exercise. (B) Serum glucose at the
end of the exercise in wild type (black bar) and different VDAC deficient mice
(white bar). The values represent the Mean±SEM, *P<0.05 vs. wild type using
a Student t-test, n≥5.
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VDAC will have an impact on glucose utilization under
conditions of high glucose flux, e.g., glucose tolerance test and
exercise. By using a skinned muscle fiber preparation, Parra et
al. [31] established an assay for direct measurement of
mitochondria-bound hexokinase activity in skeletal muscle.
This method is more accurate to determine mitochondria-bound
hexokinase because in the process of isolating mitochondria
hexokinase may be lost during the different steps of isolation.
The authors demonstrated that work induces mitochondrial
binding and enhanced catalytic activity of hexokinase in fast-
twitch muscles of the rat. By adapting the method to mouse
muscle we have demonstrated that there is a decrease in the
activity and the amount of mitochondria-bound hexokinase in
VDAC1 deficient oxidative muscles.
It is well established that both insulin and exercise rapidly
elevate glucose uptake into muscle, in part by signaling the
translocation of glucose transporters from intracellular stores to
the plasma membrane [37–42]. However, while insulin-
stimulated GLUT4 translocation is mediated via the phospha-
tidylinositol 3-kinase (PI3-K) pathway, exercise-induced glu-
cose uptake depends upon the AMP kinase signaling pathway to
mobilize a distinct intracellular pool of GLUT4 [43,44]. By
using insulin tolerance testing, we found similar insulin
sensitivity in wild type and VDAC1 deficient mice (data not
shown). More recently, studies done on conscious mouse havedemonstrated that both insulin and exercise-stimulated muscle
glucose uptake by GLUT4 are dependent on glucose phos-
phorylation capacity [45,46]. It has been also reported that in
muscle composed of type II fibers (glycolytic), glucose delivery
and glucose transport both serve to limit the rate of insulin-
stimulated muscle glucose uptake. In contrast, in soleus muscle
(composed of type I fibers), both glucose delivery and
phosphorylation are determinants of the rate of glucose uptake
[47]. Although glucose uptake has not been measured in the
present study, our data with the glucose tolerance test and
mitochondria-bound hexokinase activity in soleus do support
these findings. Due to the difficulty obtaining glycolytic muscle
from our mouse model, we restricted the study to the skeletal
muscle soleus.
While skeletal muscle, liver and fat are the primary target
tissues for glucose utilization post-prandially, a regulatory
mechanism controlled principally by insulin, skeletal muscle is
the principal site for glucose utilization during exercise, where
glucose is metabolized by anaerobic glycolysis and aerobic
oxidation to generate ATP. The data presented here do not
address whether liver or adipose tissues play a significant role in
the impaired glucose tolerance in this mouse model, and
therefore further studies are needed to address this question.
Indeed, using a proteomic approach to understand the functional
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consequences of loss of BAD, Daniel et al. [48] identified a
multiprotein complex associated with mitochondria from mouse
liver. This complex contained, amongst other proteins,
glucokinase (HK4), the majority of which resides in the
cytosol. They further demonstrated that BAD deficient mice
exhibit glucose intolerance due to reduced HK4 mitochondrial
association. They proposed that the complex regulates hepatic
glucose uptake via directing a small fraction of HK4 to
mitochondria for direct access to OXPHOS generated ATP.
Whether the phenotype observed in vdac1−/− mice is in part
related to reduced HK4 binding is currently under study. We
also speculate that a similar defect may be observed in
pancreatic beta cells.
The in vivo experiments in genetically manipulated mice are
a useful method for studying organ-specific manipulations to
selected proteins in the context of the whole animal. In mice, as
in humans, the RER value can be used to determine substrate
utilization [49]. An increase of the RER above 1.0 (anaerobic
threshold) represents the point at which CO2 production
exceeds O2 consumption and anaerobic metabolism begins to
play a predominant role in energy production due to an
imbalance in O2 demand and O2 delivery. Within the context of
the present study, neither the control nor the mutant mice
reached the anaerobic threshold. However, the double mutant
mice reached fatigue well before the wild type mice and the
RER at the end of exercise was significantly lower in the double
mutant mice in comparison to the control mice. These data
suggest that in the double mutant mice there is a larger
contribution of lipid to overall energy production, and the
exercise test uncovers a defect in the metabolic pathway of
glucose utilization as supported by a higher serum glucose
concentration at the end of the exercise. Due to the rarity of live
borne double mutant mice, the hexokinase activity in the double
mutant sample was represented by the mean of two different
points. Nevertheless, this activity is lower than the lowest value
observed for the vdac1−/− samples (data not shown). vdac1−/−/
vdac3−/− mice develop both impaired glucose and exercise
tolerance. The fact that total hexokinase activity was decreased
in the double mutant mice (data not shown) make it difficult to
correlate the phenotype observed with altered mitochondria-
bound hexokinase activity. However, the data demonstrate a
link between the capacity of glucose phosphorylation and the
stimulated state of glucose utilization. In a recent paper, Fueger
et al. [50] reported that HK2 protein content is a determinant of
exercise endurance capacity in the mouse. The authors
demonstrated that reducing HK content (50% HK knockout)
impaired endurance and increasing HK content (HK over-
expression) enhanced endurance, a finding similar to our
finding with the double mutant mice vdac1−/−/vdac3−/−. In a
previous report, the authors reported that HK2 heterozygous
mice maintained on a mixed background, in which the ca-
pacity for glucose phosphorylation is diminished, have the
same exercise capacity as wild type mice. However, under the
stress of exercise, muscle glucose uptake was impaired in
the soleus muscle [13]. Although the authors did not determine
the mitochondria-bound hexokinase activity in the heterozy-gous muscles, their data parallel our results from the vdac1−/−
mice.
In conclusion, the main finding in this report is the altered
glucose clearance in VDAC1 deficient mice. While the
underlying mechanism for such alteration is presently unknown
and could be linked to a beta cell defect or altered glucagon
secretion or altered gluconeogenesis or glycogenesis, we have
demonstrated the possibility of the existence of an additional
site for regulation of glucose utilization, mitochondria-bound
hexokinase activity.
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